T. Almammadov Et Al. , "Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity," ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12, pp.2491-2496, 2020
Almammadov, T. Et Al. 2020. Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity. ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12 , 2491-2496.
Almammadov, T., ATAKAN, G., Leylek, O., Ozcan, G., Gunbas, G., & Kolemen, S., (2020). Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity. ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12, 2491-2496.
Almammadov, Toghrul Et Al. "Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity," ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12, 2491-2496, 2020
Almammadov, Toghrul Et Al. "Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity." ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12, pp.2491-2496, 2020
Almammadov, T. Et Al. (2020) . "Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity." ACS MEDICINAL CHEMISTRY LETTERS , vol.11, no.12, pp.2491-2496.
@article{article, author={Toghrul Almammadov Et Al. }, title={Resorufin Enters the Photodynamic Therapy Arena: A Monoamine Oxidase Activatable Agent for Selective Cytotoxicity}, journal={ACS MEDICINAL CHEMISTRY LETTERS}, year=2020, pages={2491-2496} }